|
|
(12 intermediate revisions by 2 users not shown) |
Line 49: |
Line 49: |
| <p>We aimed to develop a fully-predictable regulatory program, exploiting the distributed cellular availability of specific molecular input to differentiate various cell types by the production of a protein output. Following the engineering cycle, as described in [<a href='#ref1_pd'>1</a>], our first step was “Specification”. Our end goal at the beginning, was quite singular: create a molecular logic circuit, a biocomputer, that can trigger cell death or produce fluorescence when a certain expression profile is found in a cell. Before delving deeper into the inner working of our logic circuit design, let’s review two fundamental notions concerning the computing of such circuits:</p> | | <p>We aimed to develop a fully-predictable regulatory program, exploiting the distributed cellular availability of specific molecular input to differentiate various cell types by the production of a protein output. Following the engineering cycle, as described in [<a href='#ref1_pd'>1</a>], our first step was “Specification”. Our end goal at the beginning, was quite singular: create a molecular logic circuit, a biocomputer, that can trigger cell death or produce fluorescence when a certain expression profile is found in a cell. Before delving deeper into the inner working of our logic circuit design, let’s review two fundamental notions concerning the computing of such circuits:</p> |
| <ul> | | <ul> |
− | <li style='list-style: decimal'>The nature of the biological switches. Switches are the physical entities that implement a universal set of logic gates, thus enabling computation. A plethora of biomolecules can be utilized upon which to build switches. Between gene-based, RNA-based, protein-based etc. biological switches we chose trans-acting RNA switches and specifically miRNAs. Thanks to their ability to regulate a large fraction of the human transcriptome and natural implementation NOR logic [<a href='#ref2_pd'>2</a>] when multiple ones regulate the same gene, miRNAs have been extensively studied in mammalian systems. Moreover, they are excellent internal inputs since miRNAs are found to play crucial roles in the disease spectrum [<a href='#ref3_pd'>3</a>].</li> | + | <li style='list-style: none;'><strong>1. The nature of the biological switches.</strong> Switches are the physical entities that implement a universal set of logic gates, thus enabling computation. A plethora of biomolecules can be utilized upon which to build switches. Between gene-based, RNA-based, protein-based etc. biological switches, we chose trans-acting RNA switches and specifically miRNAs. Thanks to their ability to regulate a large fraction of the human transcriptome and natural implementation NOR logic [<a href='#ref2_pd'>2</a>] when multiple ones regulate the same gene, miRNAs have been extensively studied in mammalian systems. Moreover, they are excellent internal inputs since miRNAs are found to play crucial roles in the disease spectrum [<a href='#ref3_pd'>3</a>].</li> |
− | <li style='list-style: decimal'>The rudimentary circuit abstraction. In order for a miRNA-based cell profiling to function, in accordance with seminal papers of the field [<a href='#ref2_pd'>2</a>, <a href='#ref4_pd'>4-7</a>], a number of miRNA markers is selected and the circuit computes an AND gate with these markers in order to perform a classification task.Since miRNAs are molecules exerting solely inhibitory effects on expression, a repressor is required to repress the output, “linking” the high miRNA-markers that inhibit (directly or indirectly) the production of the repressor and the low miRNA-markers that typically target the output gene. As a result, we needed to select the nature of the repressor, with options including a transcriptional one such as LacI, a post-transcriptional one like a synthetic shRNA or both, as well as the in-depth topology, by determining the layers of the circuit (two or more). More elaborate architectures can be employed by utilizing this basic architecture</li> | + | <li style='list-style: none'><strong>2. The rudimentary circuit abstraction.</strong> In order for a miRNA-based cell profiling to function, in accordance with seminal papers of the field [<a href='#ref2_pd'>2</a>, <a href='#ref4_pd'>4-7</a>], a number of miRNA markers are selected and the circuit computes an AND gate with these markers in order to perform a classification task. Since miRNAs are molecules exerting solely inhibitory effects on expression, a repressor is required to repress the output, “linking” the high miRNA-markers that inhibit (directly or indirectly) the production of the repressor and the low miRNA-markers that typically target the output gene. As a result, we needed to select the nature of the repressor, with options including a transcriptional one such as LacI, a post-transcriptional one like a synthetic miRNA or both, as well as the in-depth topology, by determining the layers of the circuit (two or more). More elaborate architectures can be employed by utilizing this basic architecture.</li> |
| </ul> | | </ul> |
− | <p>In conclusion, we’ ve set our “classification” task as follows:</p> | + | |
| + | <div style='text-align: center;'><table> |
| + | <tr> |
| + | <td><img class='sub_images' style='max-width: 100%' src='https://static.igem.org/mediawiki/2017/6/66/Greekom_results_9.png' /></td> |
| + | <td><img class='sub_images' style='max-width: 100%' src='https://static.igem.org/mediawiki/2017/9/90/Greekom_results_16.png' /></td> |
| + | <td><img class='sub_images' style='max-width: 100%' src='https://static.igem.org/mediawiki/2017/0/0d/Greekom_results_11.png' /></td> |
| + | </tr> |
| + | </table></div> |
| + | |
| + | <p>In conclusion, we set our “classification” task as follows:</p> |
| </div> | | </div> |
| </section> | | </section> |
Line 59: |
Line 68: |
| <!-- Section 3 --> | | <!-- Section 3 --> |
| <article> | | <article> |
− | <div style='text-align: center'><header><strong class='sub_headers'>Produce fluorescence or induce apoptosis when a specific miRNA expression profile* is found in colorectal cancer cells (Caco-2).</strong></header></div>
| |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
| + | <span><strong>Produce fluorescence or induce apoptosis when a specific miRNA expression profile* is found in colorectal cancer cells (Caco-2).</strong></span> |
| <p>*The miRNA expression profile should be predetermined in order to discriminate Caco-2 cells from healthy cells.</p> | | <p>*The miRNA expression profile should be predetermined in order to discriminate Caco-2 cells from healthy cells.</p> |
| </div> | | </div> |
Line 69: |
Line 78: |
| <!-- Section 4 --> | | <!-- Section 4 --> |
| <article> | | <article> |
− | <div style='text-align: center'><header><strong class='sub_headers'>Circuit topology optimization & miRNA Boolean expression selection</strong></header></div>
| |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>Εxperimental classifiers have been designed by trial-and-error, by tweaking the parameters of the network in order to identify the optimal architecture and Boolean expression, or in a semi-manual fashion, via ranking and manual selection of differentially expressed miRNAs retrieved from databases produced by large scale studies. [<a href='#ref8_pd'>8</a>] There are several constraints that dictated theses approaches, for example the inadequacy of basic building blocks to better assemble and characterize various mammalian classifiers and the lack of powerful tools to automate logic circuit design based on miRNA molecular switches. Although daunting as a task, we set off to address both of these issues by:</p> | + | <span><strong>Circuit topology optimization & miRNA Boolean expression selection</strong></span> |
− | <p>-Creating pANDORRA (programmable AND OR RNAi Assembly) in order to produce a large number of mammalian parts, which can be used for a bottom-up construction of any conceivable logic circuit based on universal logic gates</p> | + | <p>Εxperimental classifiers have been designed by trial-and-error, by tweaking the parameters of the network in order to identify the optimal architecture and Boolean expression, or in a semi-manual fashion, via ranking and manual selection of differentially expressed miRNAs retrieved from databases produced by large scale studies. [<a href='#ref8_pd'>8</a>] There are several constraints that dictated these approaches, for example the inadequacy of basic building blocks to better assemble and characterize various mammalian classifiers and the lack of powerful tools to automate logic circuit design based on miRNA molecular switches. Although daunting as a task, we set off to address both of these issues by:</p> |
| + | <p>-Creating pANDORRA (programmable AND OR RNAi Assembly) in order to produce a large number of mammalian parts, which can be used for a bottom-up construction of any conceivable logic circuit based on universal logic gates.</p> |
| <p>-Increasing the functionality and directionality of our assembly process by following a step-by-step cloning workflow and using standardized primers or overhangs after the integration of extensive technical feedback received by Stamatis Damalas. Click <a href=’https://2017.igem.org/Team:Greece/HP/Gold_Integrated’>here</a> to check it out.</p> | | <p>-Increasing the functionality and directionality of our assembly process by following a step-by-step cloning workflow and using standardized primers or overhangs after the integration of extensive technical feedback received by Stamatis Damalas. Click <a href=’https://2017.igem.org/Team:Greece/HP/Gold_Integrated’>here</a> to check it out.</p> |
− | <p>-Employing a computational framework to facilitate the selection of circuit inputs (miRNAs), form the logic expression and simulate optimal circuit-performance in different topologies. Check out<a href=’https://2017.igem.org/Team:Greece/RNAi%20Classifier%20Desig#'>our model</a> | + | <p>-Employing a computational framework to facilitate the selection of circuit inputs (miRNAs), form the logic expression and simulate optimal circuit-performance in different topologies. Check out <a href='https://2017.igem.org/Team:Greece/RNAi_Classifier_Design'>our model</a>. |
| <p>As in mature engineering clades, models simplify the real work and facilitate design in ideal conditions. Other models then evaluate the proposed designs more thoroughly and either send the designers back to the drawing board or to the test bench; that is the essence of our design approach: a progressive dance where modelling and design come ever closer together.</p> | | <p>As in mature engineering clades, models simplify the real work and facilitate design in ideal conditions. Other models then evaluate the proposed designs more thoroughly and either send the designers back to the drawing board or to the test bench; that is the essence of our design approach: a progressive dance where modelling and design come ever closer together.</p> |
| </div> | | </div> |
Line 84: |
Line 93: |
| </article> | | </article> |
| <!-- A. THE BASIC COMPONENTS OF THE CIRCUIT --> | | <!-- A. THE BASIC COMPONENTS OF THE CIRCUIT --> |
− | <article> | + | <article></br> |
− | <header><strong class='sub_headers' style='font-size: 55px;'>A. THE BASIC COMPONENTS OF THE CIRCUIT</strong></header> | + | <header><strong class='sub_headers' style='font-size: 55px;'>A. THE BASIC COMPONENTS OF THE CIRCUIT</strong></header></br> |
| <section> | | <section> |
| <!-- Section 1 --> | | <!-- Section 1 --> |
| <article> | | <article> |
− | <div style='text-align:left'><header><strong class='sub_headers'>Wet Lab Input</strong></header></div> | + | <div style='text-align:left'><header><strong class='sub_headers'>Wet Lab Input</strong></header></div></br> |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>The sequences of the plasmids used for the construction of the cell-type classifier between HeLa cells and healthy cells described in [<a href='#ref4_pd'>4</a>] were kindly provided by Prof. Xie. We've used these plasmids as a starting point to “detach” three different mammalian promoters, three different protein coding regions and two polyA signals-terminators, codon-optimize them in order to make them BioBrick compatible and order them for de novo gene synthesis. Analytically:</p> | + | <p>The sequences of the plasmids used for the construction of the cell-type classifier between HeLa cells and healthy cells described in [<a href='#ref4_pd'>4</a>] were kindly provided by Prof. Xie. We've used these plasmids as a starting point to “detach” three different mammalian promoters, four different protein coding regions and two polyA signals-terminators, codon-optimize them in order to make them BioBrick compatible and order them for de novo gene synthesis. Analytically:</p> |
| <ul> | | <ul> |
− | <li style='list-style: decimal'>Promoters | + | <li style='list-style: none'><strong>1. Promoters</strong> |
| <ul> | | <ul> |
| <li style='list-style: none'>-CMV (strong constitutive promoter from the human cytomegalovirus)</li> | | <li style='list-style: none'>-CMV (strong constitutive promoter from the human cytomegalovirus)</li> |
Line 101: |
Line 110: |
| </ul> | | </ul> |
| </li> | | </li> |
− | <li style='list-style: decimal'>Protein Coding Regions | + | <li style='list-style: none'><strong>2. Protein Coding Regions</strong> |
| <ul> | | <ul> |
| <li style='list-style: none'>-rtTA (reverse tetracycline-controlled transactivator by fusing rTetR with VP16, utilized in Tet-On systems) [<a href='#ref10_pd'>10</a>]</li> | | <li style='list-style: none'>-rtTA (reverse tetracycline-controlled transactivator by fusing rTetR with VP16, utilized in Tet-On systems) [<a href='#ref10_pd'>10</a>]</li> |
Line 110: |
Line 119: |
| </ul> | | </ul> |
| </li> | | </li> |
− | <li>polyA signals & terminators (include the motif AAUAAA which promotes both polyadenylation and termination) | + | <li style="list-style: none"><strong>3. polyA signals & terminators </strong> (include the motif AAUAAA which promotes both polyadenylation and termination) |
| <ul> | | <ul> |
| <li style='list-style: none'>-SV40 polyA</li> | | <li style='list-style: none'>-SV40 polyA</li> |
Line 117: |
Line 126: |
| </li> | | </li> |
| </ul> | | </ul> |
− | <p>*Next to the rbGlob polyA (upstream) there is a sequence coding for a synthetic miRNA, targeting a region of firefly luciferase [<a href='#ref11_pd'>11</a>]. Named FF4, it is a <strong>posttranscriptional repressor</strong>.</p> | + | <p>*Next to the rbGlob polyA (upstream) there is a sequence coding for a synthetic miRNA, targeting a region of firefly luciferase [<a href='#ref11_pd'>11</a>]. It is a <strong>post-transcriptional repressor</strong>, named FF4.</p> |
| <p>As a result, using these <a href='https://2017.igem.org/Team:Greece/Basic_Part'>Basic Parts</a>, a large number of circuit topologies can be envisioned.</p> | | <p>As a result, using these <a href='https://2017.igem.org/Team:Greece/Basic_Part'>Basic Parts</a>, a large number of circuit topologies can be envisioned.</p> |
| </div> | | </div> |
Line 123: |
Line 132: |
| </article> | | </article> |
| <!-- Section 2 --> | | <!-- Section 2 --> |
− | <article> | + | <article></br> |
− | <div style='text-align: center'><header><strong class='sub_headers'>Dry Lab Input</strong></header></div> | + | <div style='text-align: left'><header><strong class='sub_headers'>Dry Lab Input</strong></header></div> |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
Line 132: |
Line 141: |
| </article> | | </article> |
| <!-- Section 3 --> | | <!-- Section 3 --> |
− | <article> | + | <article></br> |
− | <div style='text-align: center'><header><strong class='sub_headers'>AND Logic Implementation & Output</strong></header></div> | + | <div style='text-align: left'><header><strong class='sub_headers'>Integrated Design Output</strong></header></div> |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>Thanks to this combined analysis, we have designed the Biobricks to use in the experiments/simulations and made a strong case for the case-by-case use of a transcriptioal or post-trascriptional repressor according to a the miRNA dataset.</p> | + | <p>Thanks to this combined analysis, we have designed the Biobricks to use in the experiments/simulations and made a strong case for the case-by-case use of a transcriptional or post-trascriptional repressor according to the miRNA dataset.</p> |
| </div> | | </div> |
| </section> | | </section> |
Line 143: |
Line 152: |
| </article> | | </article> |
| <!-- B. MODULAR CIRCUIT ASSEMBLY & OPTIMIZATION ALGORITHM --> | | <!-- B. MODULAR CIRCUIT ASSEMBLY & OPTIMIZATION ALGORITHM --> |
− | <article> | + | <article></br> |
− | <header><strong class='sub_headers' style='font-size: 55px;'>B. MODULAR CIRCUIT ASSEMBLY & OPTIMIZATION ALGORITHM</strong></header> | + | <header><strong class='sub_headers' style='font-size: 55px;'>B. MODULAR CIRCUIT ASSEMBLY & OPTIMIZATION ALGORITHM</strong></header></br> |
| <section> | | <section> |
| <!-- Section 1 --> | | <!-- Section 1 --> |
Line 151: |
Line 160: |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>We envisage pANDORRA as a cloning toolkit with standard parts (designed in the previous step) that can be easily applicable to the construction of a wide range of transcriptional/posttranscriptional synthetic circuits. In this endeavor, we focused on two aspects, interoperability and modularity, by <a href='https://2017.igem.org/Team:Greece/HP/Gold_Integrated'>integrating extensive technical feedback from experts in the field.</a></p> | + | <p>We envisage pANDORRA as a cloning toolkit with standard parts (designed in the previous step) that can be easily applicable to the construction of a wide range of transcriptional/post-transcriptional synthetic circuits. In this endeavor, we focused on two aspects, interoperability and modularity, by <a href='https://2017.igem.org/Team:Greece/HP/Gold_Integrated'>integrating extensive technical feedback from experts in the field.</a></p> |
| <p>According to Benenson et al., 2012 [<a href='#ref9_pd'>9</a>], an effective molecular switch or gate is characterized by:</p> | | <p>According to Benenson et al., 2012 [<a href='#ref9_pd'>9</a>], an effective molecular switch or gate is characterized by:</p> |
| <ul> | | <ul> |
− | <li style='list-style: disc'>The existence of a robust digital regime (that is, input levels that produce either a very low or a very high (saturated) output)</li> | + | <li style='list-style: disc'>The existence of a robust digital regime (that is, input levels that produce either a very low or a very high (saturated) output).</li> |
− | <li style='list-style: disc'>Gate scalability, which is the capacity to receive an increasing number of inputs without dramatic design alterations</li> | + | <li style='list-style: disc'>Gate scalability, which is the capacity to receive an increasing number of inputs without dramatic design alterations.</li> |
− | <li style='list-style: disc'>Composability, which is the capacity to operate together with other gates in parallel and/or in cascades in a predictable manner</li> | + | <li style='list-style: disc'>Composability, which is the capacity to operate together with other gates in parallel and/or in cascades in a predictable manner.</li> |
| </ul> | | </ul> |
| <p>In order to add the aforementioned features to our toolkit and to aid in the cloning process, we created various Composite Parts, that can be used to create multi-layered classifiers. At first glance, the constructs have the following general structure:</p> | | <p>In order to add the aforementioned features to our toolkit and to aid in the cloning process, we created various Composite Parts, that can be used to create multi-layered classifiers. At first glance, the constructs have the following general structure:</p> |
| <p>Promoter + Protein Coding Region + <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> + polyA signal & terminator</p> | | <p>Promoter + Protein Coding Region + <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> + polyA signal & terminator</p> |
| <p>Analytically, <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> consists of superfolder GFP (sfGFP), a very brightly fluorescent protein under the control of the bacterial constitutive promoter J23100 and is used as a reporter to simplify the validation process during cloning. </p> | | <p>Analytically, <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> consists of superfolder GFP (sfGFP), a very brightly fluorescent protein under the control of the bacterial constitutive promoter J23100 and is used as a reporter to simplify the validation process during cloning. </p> |
− | <div style='text-align:center'><img class='sub_images' style='width: 65%; height: 700px' src='https://static.igem.org/mediawiki/2017/4/4d/Greekom_Design_Petri40.jpeg' /></div> | + | <div style='text-align:center'><img class='sub_images' style='width: 500px; height: 500px' src='https://static.igem.org/mediawiki/2017/4/4d/Greekom_Design_Petri40.jpeg' /></div> |
− | <p>It is flanked by two recognition sites for BbsI, a type IIS restriction enzyme and two annealing sites for a universal M13 forward & reverse primer. As type IIS restriction enzymes recognize asymmetric DNA sequences and cleave outside of their recognition sequence, they are central to our approach for fusing miRNA target sequences into the 3’-untranslated region, as described in the next section. Examples of these constructs include:</p> | + | <p>BBa_K515105 is flanked by two recognition sites for BbsI, a type IIS restriction enzyme and two annealing sites for a universal M13 forward & reverse primer. As type IIS restriction enzymes recognize asymmetric DNA sequences and cleave outside of their recognition sequence, they are central to our approach for fusing miRNA target sequences into the 3’-untranslated region, as described in the next section. Examples of these constructs include:</p> |
| <table style='text-align:center'> | | <table style='text-align:center'> |
| <tr><td><img class='sub_images' src='https://static.igem.org/mediawiki/2017/5/58/Greekom_Design_Composite1.png' /></td></tr> | | <tr><td><img class='sub_images' src='https://static.igem.org/mediawiki/2017/5/58/Greekom_Design_Composite1.png' /></td></tr> |
Line 171: |
Line 180: |
| </table> | | </table> |
| <p>Notably, the output module can include either a coding region for a fluorescent protein, DsRed or a toxin, Apoptin (<a href='http://parts.igem.org/Part:BBa_K1061001'>BBa_K1061001</a>), a selective cancer cell killer derived from the Chicken Anemia Virus (CAV) known to cause p53-independent apoptosis in more than 70 human cancer cell lines while leaving normal cells unharmed [<a href='#ref12_pd'>12</a>]. The use of Apoptin instead of hbax [<a href='#ref4_pd'>4</a>] was a change incorporated for increased cytotoxicity and an additional safety fail-safe after discussing with <a href='https://2017.igem.org/Team:Greece/HP/Gold_Integrated'>Prof. JD Keasling and interpreting OSIRIS results.</a></p> | | <p>Notably, the output module can include either a coding region for a fluorescent protein, DsRed or a toxin, Apoptin (<a href='http://parts.igem.org/Part:BBa_K1061001'>BBa_K1061001</a>), a selective cancer cell killer derived from the Chicken Anemia Virus (CAV) known to cause p53-independent apoptosis in more than 70 human cancer cell lines while leaving normal cells unharmed [<a href='#ref12_pd'>12</a>]. The use of Apoptin instead of hbax [<a href='#ref4_pd'>4</a>] was a change incorporated for increased cytotoxicity and an additional safety fail-safe after discussing with <a href='https://2017.igem.org/Team:Greece/HP/Gold_Integrated'>Prof. JD Keasling and interpreting OSIRIS results.</a></p> |
− | <p>The aforementioned Biobricks can be used to fuse any desired complementary miRNA binding site into the 3’-untranslated region, between the BbsI restriction sites hardcoded into the coding and the terminator sequences to control the expression of each module by specific miRNAs. This process has the following requirements:</p> | + | <p>The aforementioned Biobricks can be used to fuse any desired complementary miRNA binding site (target tandem repeats) into the 3’-untranslated region, between the BbsI restriction sites hardcoded into the coding and the terminator sequences to control the expression of each module by specific miRNAs. This process has the following requirements:</p> |
| <ul> | | <ul> |
| <li style='list-style:none'>(1) Composite Parts in the form of Promoter + Protein Coding Region + <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> + polyA signal & terminator, BioBrick compatible format</li> | | <li style='list-style:none'>(1) Composite Parts in the form of Promoter + Protein Coding Region + <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> + polyA signal & terminator, BioBrick compatible format</li> |
Line 177: |
Line 186: |
| <li style='list-style:none'>(3) A set of standarized Extended Primers which are part of the MetaBrick Platform [<a href='#ref13_pd'>13</a>] that incorporate BsaI restriction sites to the Prefix-Suffix.</li> | | <li style='list-style:none'>(3) A set of standarized Extended Primers which are part of the MetaBrick Platform [<a href='#ref13_pd'>13</a>] that incorporate BsaI restriction sites to the Prefix-Suffix.</li> |
| </ul> | | </ul> |
− | <div style='text-align:center'><img class='sub_images' src='https://static.igem.org/mediawiki/2017/b/bc/Greekom_Design_pANDORRA2.png' /></div> | + | <div style='text-align:center'><img class='sub_images' style='max-width:40%' src='https://static.igem.org/mediawiki/2017/b/bc/Greekom_Design_pANDORRA2.png' /></div> |
| <p>If the aforementioned requirements are fulfilled, then the following method is followed:</p> | | <p>If the aforementioned requirements are fulfilled, then the following method is followed:</p> |
| <ul> | | <ul> |
| <li style='list-style:none'>(1) PCR amplification of the miRNA binding sites BioBricks</li> | | <li style='list-style:none'>(1) PCR amplification of the miRNA binding sites BioBricks</li> |
− | <li style='list-style:none'>(2) Digestion with BbsI of the Promoter + Protein Coding Region + <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> + polyA signal & terminator BioBricks</li> | + | <li style='list-style:none'>(2) Digestion of the Promoter + Protein Coding Region + <a href='http://parts.igem.org/Part:BBa_K515105'>BBa_K515105</a> + polyA signal & terminator BioBricks with BbsI</li> |
− | <li style='list-style:none'>(3) Digestion with BsaI of the PCR amplified miRNA binding sites BioBricks</li> | + | <li style='list-style:none'>(3) Digestion of the PCR amplified miRNA binding sites BioBricks with BsaI</li> |
− | <li style='list-style:none'>(4) The digested products have compatible sticky ends. As a result one example of the final constructs is:</li> | + | <li style='list-style:none'>(4) The digested products have compatible sticky ends. As a result, one example of the final constructs is:</li> |
| </ul></br> | | </ul></br> |
| <div style='text-align:center'><img class='sub_images' src='https://static.igem.org/mediawiki/2017/8/8b/Greekom_Design_pANDORRAfinal2.png' /></div> | | <div style='text-align:center'><img class='sub_images' src='https://static.igem.org/mediawiki/2017/8/8b/Greekom_Design_pANDORRAfinal2.png' /></div> |
Line 191: |
Line 200: |
| <!-- Section 2 --> | | <!-- Section 2 --> |
| <article> | | <article> |
− | <div style='text-align: center'><header><strong class='sub_headers'>Dry Lab Input</strong></header></div> | + | <div style='text-align: left'><header><strong class='sub_headers'>Dry Lab Input</strong></header></div> |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>The multiple architectures that emerge from the pANDORRA toolkit can be evaluated by using the <a href='https://2017.igem.org/Team:Greece/RNAi%20Classifier%20Design'>RNAi classifier design model</a> in order to recognize the optimal one for every different classification task, for example classifying Caco-2 cells. Moreover, in our model the number of repeats for miRNA binding sites is evaluated. Another point that gets elucidated is the position of the TFF4 binding site. In our models, it is adjacent to the polyA terminator as Haefliger et al., 2016 [<a href='#ref14_pd'>14</a>] showed that when the TFF4 is upstream of other binding sites, the downstream binding sites for other miRNAs are not affected by their miRNA mimics and thus optimal knockdown efficiency isn’t observed. Check the results of this process <a href='https://2017.igem.org/Team:Greece/RNAi%20Classifier%20Design'>here</a>.</p> | + | <p>The multiple architectures that emerge from the pANDORRA toolkit can be evaluated by using the <a href='https://2017.igem.org/Team:Greece/RNAi%20Classifier%20Design'>RNAi classifier design model</a> in order to recognize the optimal one for every different classification task, for example for classifying Caco-2 cells. Moreover, in our model, the number of repeats for miRNA binding sites is evaluated. Another point that gets elucidated is the position of the TFF4 binding site. In our models, it is adjacent to the polyA terminator, as Haefliger et al., 2016 [<a href='#ref14_pd'>14</a>] showed that when the TFF4 is upstream of other binding sites, the downstream binding sites for other miRNAs are not affected by their miRNA mimics and thus optimal knockdown efficiency isn’t observed. You can check the results of this process <a href='https://2017.igem.org/Team:Greece/RNAi%20Classifier%20Design'>here</a>.</p> |
| </div> | | </div> |
| </section> | | </section> |
Line 200: |
Line 209: |
| <!-- Section 3 --> | | <!-- Section 3 --> |
| <article> | | <article> |
− | <div style='text-align: center'><header><strong class='sub_headers'>AND Logic Implementation & Output</strong></header></div> | + | <div style='text-align: left'><header><strong class='sub_headers'>Integrated Design Output</strong></header></div> |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>By this back-and-forth approach, the optimal classifier can be computationally predicted and assembled from compartmentalized modules. The architectures that emerged through this exhaustive analysis have been characterized in 3 cell lines, Caco-2, HEK-293, A549. Check the results of this process <a href='https://2017.igem.org/Team:Greece/Results'>here</a>.</p> | + | <p>By this back-and-forth approach, the optimal classifier can be computationally predicted and assembled from compartmentalized modules. The architectures that emerged through this exhaustive analysis have been characterized in 3 cell lines, Caco-2, HEK-293, A549. You can check the results of this process <a href='https://2017.igem.org/Team:Greece/Results'>here</a>.</p> |
| </div> | | </div> |
| </section> | | </section> |
| </article> | | </article> |
| <!-- Section 4 --> | | <!-- Section 4 --> |
− | <article> | + | <article></br> |
− | <div style='text-align: center'><header><strong class='sub_headers'>Cancer-targeting and invasion module</strong></header></div> | + | <div style='text-align: center'><header><strong class='sub_headers'>Cancer-targeting and invasion module</strong></header></div></br> |
| <section class='sub_sections'> | | <section class='sub_sections'> |
| <div style='text-align: justify;'> | | <div style='text-align: justify;'> |
− | <p>Type I pilli, surface rod-shaped organelles 7nm in diameter and 1μm in length, are the best studied system of bacterial adhesion [<a href='#ref15_pd'>15</a>].They are heteropolymers of four proteins with FimA being the main structural protein of the pilli, which polymerizes approximately 1000 times to form a right-handed helix that constitutes the main axis of the structure and includes smaller concentrations of FimG, FimF and FimH [<a href='#ref16_pd'>16-18</a>]. FimH is the functional component of the structure as it alone confers the ability to bind to a-D-mannose of various eukaryotic cells and is located at the tip and the shafts of the pilus, whereas FimF and FimG seem to be responsible for docking FimH to FimA [<a href='#ref19_pd'>19-20</a>]. To achieve selective adhesion to colorectal cancer cells using type I pilli we need to disrupt their natural ability to bind to a-D-mannose and introduce a mechanism to facilitate adhesion to CRC cells by a mannose-independent mechanism. A mutation in the 49th amino acid of FimH has been demonstrated to completely abolish mannose binding [<a href='#ref21_pd'>21</a>]. In addition, a small peptide called RPMrel has been identified through phage display assays due to its ability to bind to five different colorectal cancer cell lines as well as cancerous tissues obtained by biopsies and not to other kinds of cancer [<a href='#ref22_pd'>22</a>]. Taken together these two modifications perform both the functions specified for CRC selective binding and have been successfully used by previous iGEM teams, iGEM Harvard 2015 and iGEM Ankara 2016 to that end. We employed the same part <a href=’http://parts.igem.org/Part:BBa_K1850011’>BBa_K1850011</a> that was submitted by iGEM Harvard 2015, in a fimH KO strain. Having achieved selective adhesion to colorectal cancer cells we move on to the second half of our device, internalization and transference of genetic material. Strains of the bacteria E. coli can be modified so that they will express two key proteins : invasin and listeriolysin O [<a href='#ref23_pd'>23-24</a>]. Invasin gives the bacteria, the ability to enter epithelial and other non phagocytic cells [<a href='#ref25_pd'>25-26</a>]. Listeriolysin O, on the other hand, has to do with what happens to the bacteria after they enter the target-cell. This particular protein allows the bacteria to free themselves of the vesicle that was used for their phagocytosis, without damaging the plasmatic/cell membrane of the target-cell. This happens due to the low pH of the vesicle (~5.9-6) that is also the optimal pH range for the protein listeriolysin [<a href='#ref27_pd'>27-28</a>]. The modified strains of <i>E. coli</i>, through expressing these proteins are able to not only enter non phagocytic target-cells that express b1-integrins but also to transfer their load to them, through escaping the phagolysosome [<a href='#ref23_pd'>23</a>]. Finally, we aim to put invasin and listeriolysin O under quorum control, through the use of the <i>lux</i> genetic circuit of <i>Vibrio fischeri</i>, as this operon has been utilized to achieve cell-density dependent invasion. During our communication with the safety committee, we were extremely glad to hear that we submitted a thorough and analytical Check In form and the Committee Members advised us to focus on the safe implementation of our classifier module and then consider a transfer method. As a result, we switched our focus and put great effort to characterize the components of our classifier to demonstrate the while integrating feedback from the scientific community about the health risks of our conceptual anticancer agent, formulating what we term, a <strong>5-STAR security system</strong>, which represents the culmination of our proposed modifications:</p> | + | <p>Type I pilli, surface rod-shaped organelles of 7nm in diameter and 1μm in length, are the best studied system of bacterial adhesion [<a href='#ref15_pd'>15</a>].They are heteropolymers of four proteins with FimA being the main structural protein of the pilli, which polymerizes approximately 1000 times to form a right-handed helix that constitutes the main axis of the structure and includes smaller concentrations of FimG, FimF and FimH [<a href='#ref16_pd'>16-18</a>]. FimH is the functional component of the structure as it alone confers the ability to bind to a-D-mannose of various eukaryotic cells and is located at the tip and the shafts of the pilus, whereas FimF and FimG seem to be responsible for docking FimH to FimA [<a href='#ref19_pd'>19-20</a>]. To achieve selective adhesion to colorectal cancer cells using type I pilli we need to disrupt their natural ability to bind to a-D-mannose and introduce a mechanism to facilitate adhesion to CRC cells by a mannose-independent mechanism. A mutation in the 49th amino acid of FimH has been demonstrated to completely abolish mannose binding [<a href='#ref21_pd'>21</a>]. In addition, a small peptide called RPMrel has been identified through phage display assays due to its ability to bind to five different colorectal cancer cell lines as well as cancerous tissues obtained by biopsies and not to other kinds of cancer [<a href='#ref22_pd'>22</a>]. Taken together these two modifications perform both the functions specified for CRC selective binding and have been successfully used by previous iGEM teams, iGEM Harvard 2015 and iGEM Ankara 2016 to that end. We employed the same part <a href=’http://parts.igem.org/Part:BBa_K1850011’>BBa_K1850011</a> that was submitted by iGEM Harvard 2015, in a fimH KO strain. Having achieved selective adhesion to colorectal cancer cells we move on to the second half of our device, internalization and transference of genetic material. Strains of the bacteria E. coli can be modified so that they will express two key proteins : invasin and listeriolysin O [<a href='#ref23_pd'>23-24</a>]. Invasin gives the bacteria, the ability to enter epithelial and other non phagocytic cells [<a href='#ref25_pd'>25-26</a>]. Listeriolysin O, on the other hand, has to do with what happens to the bacteria after they enter the target-cell. This particular protein allows the bacteria to free themselves of the vesicle that was used for their phagocytosis, without damaging the plasmatic/cell membrane of the target-cell. This happens due to the low pH of the vesicle (~5.9-6) that is also the optimal pH range for the protein listeriolysin [<a href='#ref27_pd'>27-28</a>]. The modified strains of <i>E. coli</i>, through expressing these proteins are able to not only enter non phagocytic target-cells that express b1-integrins but also to transfer their load to them, through escaping the phagolysosome [<a href='#ref23_pd'>23</a>]. Finally, we aim to put invasin and listeriolysin O under quorum control, through the use of the <i>lux</i> genetic circuit of <i>Vibrio fischeri</i>, as this operon has been utilized to achieve cell-density dependent invasion. During our communication with the safety committee, we were extremely glad to hear that we submitted a thorough and analytical Check In form and the Committee Members advised us to focus on the safe implementation of our classifier module and then consider a transfer method. As a result, we switched our focus and put great effort to characterize the components of our classifier to demonstrate the while integrating feedback from the scientific community about the health risks of our conceptual anticancer agent, formulating what we term, a <strong>5-STAR security system</strong>, which represents the culmination of our proposed modifications:</p> |
| <strong> | | <strong> |
| Level 1:</br> | | Level 1:</br> |